David Del Bourgo
Directeur Général chez Whitelab Genomics SAS
Profil
David Del Bourgo is the founder and current Chief Executive Officer of Whitelab Genomics SAS, which he founded in 2019.
He was also a Manager-Strategic Consulting at Advention Business Partners SAS in 2006.
Mr. Del Bourgo holds an MBA degree from The University of Chicago, which he received in 2006, and a graduate degree from Université de Technologie de Compiègne, which he received in 1997.
Postes actifs de David Del Bourgo
| Sociétés | Poste | Début |
|---|---|---|
Whitelab Genomics SAS
 Whitelab Genomics SAS Packaged SoftwareTechnology Services Whitelab Genomics SAS is a French company that develops software solutions using AI to accelerate and de-risk gene and cell therapy developments. The company is based in Evry, France. The company's analytical solutions provide a wide range of answers to scientific and technological questions. The company is developing a unique AI platform dedicated to accelerated gene and cell therapy development. The company was founded in 2019 by David Del Bourgo, Julien Cottineau. David Del Bourgo has been the CEO since 2019. | Directeur Général | 01/01/2019 |
Anciens postes connus de David Del Bourgo
| Sociétés | Poste | Fin |
|---|---|---|
Advention Business Partners SAS
 Advention Business Partners SAS Investment ManagersFinance Advention Business Partners SAS provides investment consulting services. It offers its expertise to the consumer goods and retails; financial services; healthcare; manufacturing; private equity; social and public sector; utilities; tecnology; media; and telecommunications industries. The company was founded by Jean-Michel Schmitt and Anthony W. Besso in 2001 and is headquartered in Paris, France. | Corporate Officer/Principal | 01/01/2006 |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Corporate Officer/Principal | - |
| GENOMIC VISION | Sales & Marketing | - |
| ORBOTECH LTD | Corporate Officer/Principal | - |
| THERACLION | Corporate Officer/Principal | 05/06/2012 |
Formation de David Del Bourgo
| The University of Chicago | Masters Business Admin |
| Université de Technologie de Compiègne | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENOMIC VISION | Health Technology |
| THERACLION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Orbotech Ltd.
 Orbotech Ltd. Electronic ComponentsElectronic Technology Orbotech Ltd. designs, develops, manufactures, markets, and services automated optical inspection systems for bare printed circuit boards and flat panel displays. The company was founded on February 8, 1981 and is headquartered in Yavne, Israel. | Electronic Technology |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
Advention Business Partners SAS
Advention Business Partners SAS Investment ManagersFinance Advention Business Partners SAS provides investment consulting services. It offers its expertise to the consumer goods and retails; financial services; healthcare; manufacturing; private equity; social and public sector; utilities; tecnology; media; and telecommunications industries. The company was founded by Jean-Michel Schmitt and Anthony W. Besso in 2001 and is headquartered in Paris, France. | Finance |
Whitelab Genomics SAS
Whitelab Genomics SAS Packaged SoftwareTechnology Services Whitelab Genomics SAS is a French company that develops software solutions using AI to accelerate and de-risk gene and cell therapy developments. The company is based in Evry, France. The company's analytical solutions provide a wide range of answers to scientific and technological questions. The company is developing a unique AI platform dedicated to accelerated gene and cell therapy development. The company was founded in 2019 by David Del Bourgo, Julien Cottineau. David Del Bourgo has been the CEO since 2019. | Technology Services |